<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30521834</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-9096</ISSN><JournalIssue CitedMedium="Internet"><Volume>162</Volume><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Antiviral research</Title><ISOAbbreviation>Antiviral Res</ISOAbbreviation></Journal><ArticleTitle>Development of a respiratory disease model for enterovirus D68 in 4-week-old mice for evaluation of antiviral therapies.</ArticleTitle><Pagination><StartPage>61</StartPage><EndPage>70</EndPage><MedlinePgn>61-70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.antiviral.2018.11.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0166-3542(18)30343-7</ELocationID><Abstract><AbstractText>Enterovirus D68 (EV-D68) is a non-polio enterovirus that affects the respiratory system and can cause serious complications, especially in children and older people with weakened immune systems. As an emerging virus, there are no current antiviral therapies or vaccines available. Our goal was to develop a mouse model of human EV-D68 infection that mimicked the disease observed in humans and could be used for evaluation of experimental therapeutics. This is the first report of a respiratory disease model for EV-D68 infection in mice. We adapted the virus by 30 serial passages in AG129 mice, which are deficient in IFN- &#x3b1;/&#x3b2; and -&#x3b3; receptors. Despite a lack of weight loss or mortality in mice, lung function measured by plethysmography, showed an increase in enhanced pause (Penh) on days 6 and 7 post-infection. In addition, as virus adapted to mice, virus titer in the lungs increased 50-fold, and the pro-inflammatory cytokines MCP-1 and RANTES increased 15-fold and 2-fold in the lung, respectively. In addition, a time course of mouse-adapted EV-D68 infection was determined in lung, blood, liver, kidney, spleen, leg muscle, spinal cord and brain. Virus in the lung replicated rapidly after intranasal inoculation of adapted virus, 10<sup>6</sup> CCID<sub>50</sub>/mL by 4&#x202f;h and 10<sup>8.3</sup> CCID<sub>50</sub>/mL by 24&#x202f;h. Virus then spread to the blood and other tissues, including spinal cord and brain. This mouse model for EV-D68 infection includes enhanced pause (Penh) as an indicator of morbidity, and viremia, virus titers and proinflammatory cytokines in the lung, and lung histopathology as indicators of disease. Our mouse-adapted virus has a similar antiviral profile to the original isolate as well as another respiratory picornavirus, rhinovirus-14. This model will be valuable in evaluating experimental therapies in the future.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>W Joseph</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Institute for Antiviral Research, Utah State University, Logan, UT, USA; Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurst</LastName><ForeName>Brett L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Institute for Antiviral Research, Utah State University, Logan, UT, USA; Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peterson</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Institute for Antiviral Research, Utah State University, Logan, UT, USA; Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Wettere</LastName><ForeName>Arnaud J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA; Utah Veterinary Diagnostic Laboratory, Logan, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Day</LastName><ForeName>Craig W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Institute for Antiviral Research, Utah State University, Logan, UT, USA; Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smee</LastName><ForeName>Donald F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Institute for Antiviral Research, Utah State University, Logan, UT, USA; Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarbet</LastName><ForeName>E Bart</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Institute for Antiviral Research, Utah State University, Logan, UT, USA; Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA; Utah Veterinary Diagnostic Laboratory, Logan, UT, USA. Electronic address: bart.tarbet@usu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HHSN272201000039C</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN272201000039I</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Antiviral Res</MedlineTA><NlmUniqueID>8109699</NlmUniqueID><ISSNLinking>0166-3542</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018925">Chemokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018925" MajorTopicYN="N">Chemokines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="N">Enterovirus D, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014766" MajorTopicYN="N">Viremia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AG129 mice</Keyword><Keyword MajorTopicYN="N">Animal model</Keyword><Keyword MajorTopicYN="N">Enterovirus D68</Keyword><Keyword MajorTopicYN="N">Respiratory disease</Keyword></KeywordList><CoiStatement>Conflicts of Interest. The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>2</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30521834</ArticleId><ArticleId IdType="mid">NIHMS1517104</ArticleId><ArticleId IdType="pmc">PMC6997929</ArticleId><ArticleId IdType="doi">10.1016/j.antiviral.2018.11.012</ArticleId><ArticleId IdType="pii">S0166-3542(18)30343-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barnard DL, Hubbard VD, Smee DF, Sidwell RW, Watson KG, Tucker SP, Reece PA, 2004. In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity. Antimicrob Agents Chemother 48, 1766&#x2013;1772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC400527</ArticleId><ArticleId IdType="pubmed">15105133</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartlett NW, Singanayagam A, Johnston SL, 2015. Mouse models of rhinovirus infection and airways disease. Methods Mol Biol 1221, 181&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">25261315</ArticleId></ArticleIdList></Reference><Reference><Citation>Fla&#xf1;o E, Jewell NA, Durbin RK, Durbin JE. 2009. Methods used to study respiratory virus infection. Current protocols in cell biology / editorial board, Juan S Bonifacino. [Chapter:26.3].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2753376</ArticleId><ArticleId IdType="pubmed">19499505</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster CB, Friedman N, Carl J, Piedimonte G. 2015. Enterovirus D68: a clinically important respiratory enterovirus. Cleve Clin J Med 82:26&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">25552624</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger AL, Naccache SN, Messacar K, Clayton A, Yu G, Somasekar S, Federman S, Stryke D, Anderson C, Yagi S, Messenger S, Wadford D, Xia D, Watt JP, Van Haren K, Dominguez SR, Glaser C, Aldrovandi G, Chiu CY. 2015. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort study. Lancet Infect Dis 15:671&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6027625</ArticleId><ArticleId IdType="pubmed">25837569</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon AM, Yu G, Leser JS, Yagi S, Clarke P, Chiu CY, Tyler KL. 2017. A mouse model of paralytic myelitis caused by enterovirus D68. PLoS Pathog 13:e1006199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5322875</ArticleId><ArticleId IdType="pubmed">28231269</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst BL, Evans WJ, Smee DF, Van Wettere A, Tarbet EB 2019. Evaluation of Antiviral Therapies in Respiratory and Neurological Disease Models of Enterovirus D68 Infection in AG129 Mice. Virology 526:146&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6309259</ArticleId><ArticleId IdType="pubmed">30390563</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura T, Oshitani H. 2015. Erratum: Global reemergence of enterovirus D68 as an important pathogen for acute respiratory infections. Rev Med Virol 25:268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4738597</ArticleId><ArticleId IdType="pubmed">26151890</ArticleId></ArticleIdList></Reference><Reference><Citation>Julander JG, Hagloch J, Latimer S, Motter N, Dagley A, Barnard DL, Smee DF, and Morrey JD. 2011. Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus. Antiviral Res 92:228&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">21867731</ArticleId></ArticleIdList></Reference><Reference><Citation>Loddo B, Ferrari W, Brotzu G, Spanedda A. 1962. In vitro inhibition of infectivity of polio viruses by guanidine. Nature 193:97&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">14466152</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin G, Li R, Cook VE, Carwana M, Tilley P, Sauve L, Tang P, Kapur A, Yang CL. 2016. Respiratory Presentation of Pediatric Patients in the 2014 Enterovirus D68 Outbreak. Can Respir J 2016:8302179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5004002</ArticleId><ArticleId IdType="pubmed">27610028</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto M, Awano H, Ogi M, Tomioka K, Unzaki A, Nishiyama M, Toyoshima D, Taniguchi-Ikeda M, Ishida A, Nagase H, Morioka I, Iijima K. 2016. A pediatric patient with interstitial pneumonia due to enterovirus D68. J Infect Chemother 22:712&#x2013;715.</Citation><ArticleIdList><ArticleId IdType="pubmed">27118532</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Abzug MJ, Dominguez SR. 2016. 2014 outbreak of enterovirus D68 in North America. J Med Virol 88:739&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pubmed">26489019</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Schreiner TL, Maloney JA, Wallace A, Ludke J, Oberste MS, Nix WA, Robinson CC, Glode MP, Abzug MJ, Dominguez SR. 2015. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet 385:1662&#x2013;1671.</Citation><ArticleIdList><ArticleId IdType="pubmed">25638662</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley CM, Jackson MA, Selvarangan R, Turabelidze G, Obringer E, Johnson D, Giles BL, Patel A, Echols F, Oberste MS, Nix WA, Watson JT, Gerber SI. 2014. Severe respiratory illness associated with enterovirus D68 - Missouri and Illinois, 2014. MMWR Morb Mortal Wkly Rep 63:798&#x2013;799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4584696</ArticleId><ArticleId IdType="pubmed">25211545</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley CM, Watson JT, Nix WA, Curns AT, Rogers SL, Brown BA, Conover C, Dominguez SR, Feikin DR, Gray S, Hassan F, Hoferka S, Jackson MA, Johnson D, Leshem E, Miller L, Nichols JB, Nyquist AC, Obringer E, Patel A, Patel M, Rha B, Schneider E, Schuster JE, Selvarangan R, Seward JF, Turabelidze G, Oberste MS, Pallansch MA, Gerber SI, Group E-DW. 2015. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation. Lancet Respir Med 3:879&#x2013;887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5693332</ArticleId><ArticleId IdType="pubmed">26482320</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918&#x2013;1921.</Citation><ArticleIdList><ArticleId IdType="pubmed">8009221</ArticleId></ArticleIdList></Reference><Reference><Citation>National Research Council (U.S.) Committe for the Update of the Guide for the Care and Use of Laboratory Animals IfLARUS, National Academies Press (U.S.). 2011. Guide for the care and use of Laboratory Animals National Academies Press,</Citation></Reference><Reference><Citation>Oberste MS, Maher K, Schnurr D, Flemister MR, Lovchik JC, Peters H, Sessions W, Kirk C, Chatterjee N, Fuller S, Hanauer JM, Pallansch MA. 2004. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J Gen Virol 85:2577&#x2013;2584.</Citation><ArticleIdList><ArticleId IdType="pubmed">15302951</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg AC, Gern JE. 2015. Classification and evolution of human rhinoviruses. Methods Mol Biol 1221:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4441521</ArticleId><ArticleId IdType="pubmed">25261302</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MC, Wang W, Pletneva LM, Rajagopala SV, Tan Y, Hartert TV, Boukhvalova MS, Vogel SN, Das SR, Blanco JC. 2016. Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus). PLoS One 11:e0166336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5096705</ArticleId><ArticleId IdType="pubmed">27814404</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ and Muench H. 1938. A simple method of estimating fifty percent endpoints. American Journal of tropical medicine and Hygiene 27:493&#x2013;197.</Citation></Reference><Reference><Citation>Rhoden E, Zhang M, Nix WA, Oberste MS. 2015. In Vitro Efficacy of Antiviral Compounds against Enterovirus D68. Antimicrob Agents Chemother 59:7779&#x2013;7781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4649146</ArticleId><ArticleId IdType="pubmed">26149998</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster JE, Miller JO, Selvarangan R, Weddle G, Thompson MT, Hassan F, Rogers SL, Oberste MS, Nix WA, Jackson MA. 2015. Severe enterovirus 68 respiratory illness in children requiring intensive care management. J Clin Virol 70:77&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">26305825</ArticleId></ArticleIdList></Reference><Reference><Citation>Smee DF, Barnard DL. 2013. Methods for evaluation of antiviral efficacy against influenza virus infections in animal models. Methods Mol Biol 1030:407&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">23821285</ArticleId></ArticleIdList></Reference><Reference><Citation>Smee DF, Evans WJ, Nicolaou KC, Tarbet EB, Day CW. 2016. Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds. Antiviral Res 131:61&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5100981</ArticleId><ArticleId IdType="pubmed">27063860</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Meijer A, Froeyen M, Zhang L, Thibaut HJ, Baggen J, George S, Vernachio J, van Kuppeveld FJ, Leyssen P, Hilgenfeld R, Neyts J, Delang L. 2015. Antiviral Activity of Broad-Spectrum and Enterovirus-Specific Inhibitors against Clinical Isolates of Enterovirus D68. Antimicrob Agents Chemother 59:7782&#x2013;7785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4649165</ArticleId><ArticleId IdType="pubmed">26369972</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Broek MF, Muller U, Huang S, Aguet M, Zinkernagel RM. 1995. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol 69:4792&#x2013;4796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189290</ArticleId><ArticleId IdType="pubmed">7609046</ArticleId></ArticleIdList></Reference><Reference><Citation>Wylie TN, Wylie KM, Buller RS, Cannella M, Storch GA. 2015. Development and Evaluation of an Enterovirus D68 Real-Time Reverse Transcriptase PCR Assay. J Clin Microbiol 53:2641&#x2013;2647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4508392</ArticleId><ArticleId IdType="pubmed">26063859</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng HW, Sun M, Guo L, Wang JJ, Song J, Li JQ, Li HZ, Ning RT, Yang ZN, Fan HT, He ZL, Liu LD. 2017. Nasal Infection of Enterovirus D68 Leading to Lower Respiratory Tract Pathogenesis in Ferrets (Mustela putorius furo). Viruses 9(5). pii: E104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5454417</ArticleId><ArticleId IdType="pubmed">28489053</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>